Driving force in drug development
Portugal’s best teams in science and clinics have joined forces to provide cutting-edge, customized solutions in drug development for academia and industry
Previous Work
Applying CellectAB technology to generate antibodies against CD3
Alginate Hydrogels for Medical Applications
Developing a xenograft mouse model of canine diffuse large B-cell lymphoma (DLBCL)
Process Development of Bacteriophages for application in Diagnostic Kits for the Food Industry
Assay development for the evaluationof antiviral COVID-19 surface coatings
Investigating the potential of new therapeutic strategies relevant for the treatment of glaucoma
news & announcements
VectorB2B will be at “Bio-Europe Spring 2021”
Vector B2B will be participating in the Bio-Europe Spring 2021 between March 22-25. Bio-Europe Spring is the European largest springtime digital partnering event with the aim of
Interview with Miguel Garcia
Miguel Garcia is the co-founder and CEO of TechnoPhage, one of the companies with the highest R&D in Portugal. Miguel Garcia is also one
contact us
Vector B2B
Drug Developing – Associação para Investigação em Biotecnologia
Address
Avenida Professor Gama Pinto nº.2
Alameda da Universidade,
Cidade Universitária
1649-003 Lisboa
E-mail
info@vectorb2b.com
